EUVIMEDEUVIMED entdecken
Crossref

Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany

Kerstin N Vokinger, Emanuel Nussli, Stacie B Dusetzina

JAMA Internal Medicine · 01.09.2024 · 184 (9) · 1002

DOI: 10.1001/jamainternmed.2024.2559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2024. Verfasst von Kerstin N Vokinger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Academic Chair for Regulation in Law, Medicine, and Technology, Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1HumansUnited StatesSwitzerlandCanadaGermanyHealth Services AccessibilityAnti-Obesity AgentsObesityWeight Loss

Substanzen

Glucagon-Like Peptide 1Anti-Obesity Agents

Autor:innen und Institutionen

  • Academic Chair for Regulation in Law, Medicine, and Technology, Faculty of Law and Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

Zitieren

APA

Vokinger, K. N., Nussli, E., & Dusetzina, S. B. (2024). Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany. JAMA Internal Medicine, 184(9), 1002. https://doi.org/10.1001/jamainternmed.2024.2559

Vancouver

Vokinger KN, Nussli E, Dusetzina SB. Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany. JAMA Internal Medicine. 2024;184(9):1002. doi:10.1001/jamainternmed.2024.2559

BibTeX
@article{Vokinger2024,
  author = {Vokinger, Kerstin N and Nussli, Emanuel and Dusetzina, Stacie B},
  title = {Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany},
  journal = {JAMA Internal Medicine},
  year = {2024},
  volume = {184},
  number = {9},
  pages = {1002},
  doi = {10.1001/jamainternmed.2024.2559}
}
Kostenlos starten →